ArticleBMC cancer2026

Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.

Xueyan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.